Selumetinib Pharmacokinetics1. AbsorptionMean absolute bioavailability in adults: 62%.Median time to peak concentration at steady state in pediatric p···【Read More】
Update: 2026-07-07Source: Haiou HealthViews: 162
In SPRINT Phase II study Layer 1, adverse reactions reported at an incidence ≥40% in pediatric patients were: vomiting, rash, abdominal pain, diarrhea···【Read More】
Update: 2026-07-07Source: Haiou HealthViews: 140
Selumetinib side effects vary in severity; if you encounter any issues, please consult your doctor promptly.Serious side effects of SelumetinibDuring ···【Read More】
Update: 2026-07-07Source: Haiou HealthViews: 144
Selumetinib Drug Interaction Dose AdjustmentCo-administration with Strong/Moderate CYP3A4 Inhibitors or FluconazolePrinciple: Avoid concomitant use wh···【Read More】
Update: 2026-07-07Source: Haiou HealthViews: 165
Selumetinib Dosage Adjustments for Adverse ReactionsIf intolerance persists after two dose reductions, permanently discontinue.Dose Reduction Scheme B···【Read More】
Update: 2026-07-06Source: Haiou HealthViews: 161
Selumetinib dosage and administration: What is the dosage of Selumetinib? The dosage is based on body surface area (BSA). The usual recommended dose i···【Read More】
Update: 2026-07-03Source: Haiou HealthViews: 147
For pregnant and lactating patients, if Sotorasib is to be used, it should be strictly in accordance with the doctor's advice, and do not use the ···【Read More】
Update: 2026-07-03Source: Haiou HealthViews: 179
Sotorasib Daily PrecautionsWhat daily precautions should be taken during Sotorasib treatment? It is important to actively maintain contact with your d···【Read More】
Update: 2026-07-03Source: Haiou HealthViews: 142
Mechanism of Action of SotorasibIrreversibly and selectively inhibits KRASG12C mutation, selectively inhibits KRAS signaling and cell growth in vitro,···【Read More】
Update: 2026-07-03Source: Haiou HealthViews: 151
Sotorasib is the first approved KRAS G12C-targeted therapy, indicated for the treatment of non-small cell lung cancer and colorectal cancer with KRAS ···【Read More】
Update: 2026-07-03Source: Haiou HealthViews: 128
Side Effects of SotorasibHematologicVery common (≥10%): lymphopenia (up to 48%), decreased hemoglobin (up to 43%), prolonged activated partial thrombo···【Read More】
Update: 2026-07-03Source: Haiou HealthViews: 143
Use of Sotorasib may cause a range of side effects, some of which are serious and require prompt medical attention. During treatment with Sotorasib, c···【Read More】
Update: 2026-07-02Source: Haiou HealthViews: 155
If adverse reactions occur, a maximum of 2 dose reductions are permitted: first dose reduction, 480 mg orally once daily; second dose reduction, 240 m···【Read More】
Update: 2026-07-01Source: Haiou HealthViews: 171
Sotorasib is indicated for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at leas···【Read More】
Update: 2026-06-30Source: Haiou HealthViews: 159
For HR-positive, HER2-negative breast cancer patients, the abemaciclib (BESIDX) from Lao Big Bear Pharmaceutical not only continues the clinical value···【Read More】
Update: 2026-06-25Source: Haiou HealthViews: 162
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos